Terms: = Breast cancer AND PBRM1, BAF180, 55193, PB1, MGC156156, MGC156155 AND Treatment
5 results:
1. Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.
Li K; Cao L; Li C; Wu J; Chen B; Zhang G; Li X; Wen L; Jia M; Wei G; Lin J; Li Y; Zhang Y; Mok H; Ren C; Wang Y; Qi X; Guo L; Che Y; Liao N
Cancer Med; 2023 Mar; 12(5):5195-5208. PubMed ID: 36404592
[TBL] [Abstract] [Full Text] [Related]
2. miR526b and miR655 Induce Oxidative Stress in breast cancer.
Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
[TBL] [Abstract] [Full Text] [Related]
3. Mapping Bromodomains in breast cancer and association with clinical outcome.
Pérez-Pena J; Páez R; Nieto-Jiménez C; Sánchez VC; Galan-Moya EM; Pandiella A; Győrffy B; Ocana A
Sci Rep; 2019 Apr; 9(1):5734. PubMed ID: 30952871
[TBL] [Abstract] [Full Text] [Related]
4. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
[TBL] [Abstract] [Full Text] [Related]
5. baf180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.
Xia W; Nagase S; Montia AG; Kalachikov SM; Keniry M; Su T; Memeo L; Hibshoosh H; Parsons R
Cancer Res; 2008 Mar; 68(6):1667-74. PubMed ID: 18339845
[TBL] [Abstract] [Full Text] [Related]
